News - Page 4 of 15 - Lymphoma Australia

published May 8, 2025
Dec 2023 Inside this edition, keeping safe and eating well over the festive period, christmas closures
published May 8, 2025
Sep 2023 Learn about hair loss with treatment, our advocacy for CAR T-cell therapy and more.
published May 8, 2025
January 2023 Inside this edition, we will be covering the following topics:2023 & What we have plan
published May 8, 2025
Jan 2023 Welcome to 2023. In this edition you can learn about what we have planned for 2023.
published April 28, 2025
Roughly 800 people are diagnosed with Hodgkin Lymphoma each year in Australia, and both adults and children ca
published April 14, 2025
Chimeric Antigen Receptor T-cell Therapy – better known as  CAR T-cell therapy is a treatment for people with
published April 7, 2025
The TGA has approved zanubrutinib for more people with lymphoma, and some of these are now PBS listed.
published April 2, 2025
CAR T-cell therapy is an advanced treatment that helps your immune system fight the lymphoma. It involves coll
published April 2, 2025
Epcoritamab, (brand name EPKINLY®) is a new bispecific antibody treatment. It is now provisionally approved i
published January 23, 2025
LEDAGA® now PBS listed for patients with limited stage Mycosis Fungoides T-cell lymphoma.
published July 23, 2024
We are here to support people affected by lymphoma or CLL.
published July 12, 2024
Gilead welcomes the opening of Australia’s first regional CAR T-cell treatment centre at Townsville Hospital

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.